Roy C. Hardiman, Chief Business Officer at Principia Biopharma Inc. (PRNB), sold 9,900 shares at $49.46 ($481K) on 2020-03-13, disclosed to the SEC on 2020-03-17.
Open-market sale of $481k PRNB by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.21 | 3,719 | $179K | 37.3% |
| 2 | $48.21 | 3,719 | $179K | 37.3% |
| 3 | $49.46 | 1,181 | $58K | 12.2% |
| 4 | $49.46 | 1,181 | $58K | 12.2% |
| 5 | $51.04 | 100 | $5K | 1.1% |
| Total | $48.54 avg | 9,900 |
| $481K |
| 100% |
| Filing → |
| PRNB | SELL | 2019-12-13 | $494K | — | Filing → |